LineaRx - an Applied DNA Sciences company

Stony Brook,  NY 
United States

LineaRx, an Applied DNA Sciences, Inc. company (NASDAQ: APDN) delivers enzymatically-produced LinearDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Manufactured by a proprietary, large-scale polymerase chain reaction (“PCR”) based manufacturing platform, LinearDNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences.


  • Linea™ IVT - Better mRNA…Faster
    Linea™ IVT is the combination of LRx’s enzymatically produced Linea DNA IVT templates and its proprietary Linea RNA polymerase.